Don't want to trade it yourself?
Our desk runs DEX portfolios on profit share.
Wall Street analysts remain optimistic on Strategy (MSTR), with the MSCI-related issue already priced into the stock, CryptoQuant CEO Ki Young Ju said on X.
Ki said Citigroup has a $240 price target on MSTR, while Barclays has set a $175 target and B. Riley a $195 target. He added that those targets remain on an upward trend rather than a downward one. The MSCI issue is related to fund flows and has already been reflected in the share price, Ki said. What matters now, he said, is that Strategy’s market capitalization-to-net asset value multiple is around one, its preferred stock STRC is trading near par value, and it has secured a $3.75 billion reserve to support dividend payments.